SCHEMBL7325611

SCHEMBL7325611

CC1(C)CCN(C(=O)[C@@H](N)Cc2c[nH]cn2)[C@@H]1C(=O)NC(=O)[C@@H]1CCC(=O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7326055 0.95 DPP4 (0.30) —
SCHEMBL7323929 0.93 — —
SCHEMBL7265751 0.85 TRHR (0.32) —
SCHEMBL7325603 0.83 TRHR (0.40) —
SCHEMBL7333371 0.83 TRHR (0.40) —
SCHEMBL7273287 0.80 DPP4 (0.34) —
SCHEMBL7333426 0.80 DPP4 (0.34) —
Bromide SCHEMBL7330456 0.79 DPP4 (0.33) —
SCHEMBL7326040 0.79 TRHR (0.41) —
SCHEMBL7333027 0.77 DPP4 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0384380-B1 Novel peptide derivatives and their pharmaceutical use JAPAN TOBACCO INC (JP) 1996-06-19 — — EP claimed
EP-0384380-B1 Novel peptide derivatives and their pharmaceutical use JAPAN TOBACCO INC (JP) 1996-06-19 — — EP disclosed
EP-0384380-A2 Novel peptide derivatives and their pharmaceutical use JAPAN TOBACCO INC. (JP) 1990-08-29 — — EP disclosed
Send feedback